PodParley PodParley

Hyperglycaemia Within the Acute Setting (29 Mar 2021)

Dr Rachel Sutherland interviews Prof Mark Stracha…

An episode of the Clinical Conversations podcast, hosted by Royal College of Physicians of Edinburgh, titled "Hyperglycaemia Within the Acute Setting (29 Mar 2021)" was published on March 29, 2021 and runs 37 minutes.

March 29, 2021 ·37m · Clinical Conversations

0:00 / 0:00

Dr Rachel Sutherland interviews Prof Mark Strachan about how to approach the hyperglycaemic patient who presents in the acute receiving unit. Professor Mark Strachan is a Consultant Physician in Endocrinology, Diabetes and Acute Medicine at the Western General Hospital, Edinburgh and Honorary Professor of the University of Edinburgh. Dr Sutherland is a Consultant in Stroke and General Medicine in the South East of Scotland. She has an interest in integrated, real time analytics and spent some time outside of medicine working as a medical informaticist. She is a passionate advocate for Flexible working and training for doctors. Feedback and suggested future topics are very welcome, please contact us via email at: [email protected]

Dr Rachel Sutherland interviews Prof Mark Strachan about how to approach the hyperglycaemic patient who presents in the acute receiving unit. Professor Mark Strachan is a Consultant Physician in Endocrinology, Diabetes and Acute Medicine at the Western General Hospital, Edinburgh and Honorary Professor of the University of Edinburgh. Dr Sutherland is a Consultant in Stroke and General Medicine in the South East of Scotland. She has an interest in integrated, real time analytics and spent some time outside of medicine working as a medical informaticist. She is a passionate advocate for Flexible working and training for doctors. Feedback and suggested future topics are very welcome, please contact us via email at: [email protected]
Clinical Trial Podcast | Conversations with Clinical Research Experts Kunal Sampat | Educator Clinical research and clinical trial management form the backbone of drug and device approvals worldwide. Learn from the leading industry experts to build and advance your clinical research career.You'll hear from sponsors, clinical research organizations, and clinical trial sites around the globe. This show is for all current and aspiring clinical research professionals including clinical research associates (CRA), clinical operations managers, study managers, biostatisticians, medical doctors, safety monitors, clinical scientists and other healthcare professionals. To learn more, visit https://clinicaltrialpodcast.com/ Primary Care Today ReachMD Primary Care Today features conversations with clinical experts representing a wide range of medical specialties to highlight the latest trends in primary care practice, from clinical pearls to updated guidelines, health informatics, and practice management. This series is hosted by Dr. Brian McDonough, a nationally recognized clinical expert, teacher, and public speaker in primary care. Few & Far Between: How Biotech Gets Built Chris O'Brien Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders. Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Julio G. Martinez-Clark Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.What You’ll Learn:Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.Why Listen?<ul
URL copied to clipboard!